A Johns Hopkins study reveals that anti-VEGF treatments for wet AMD may unintentionally elevate ANGPTL4, a protein that ...

The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).

Formosa Pharmaceuticals has announced the completion and top-line results from CPN-303, a phase 3 clinical study of APP13007 ...

FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

The investigators conducted a randomized controlled trial of 60 patients who underwent monitored anesthesia care sedation for ...

200 mg of caffeine elevated the blood pressure after 2 hours but did not impact the retinal VD.

Omar Salamanca, MD, staff ophthalmologist, Orbis Flying Eye Hospital, discusses Orbis's tailored glaucoma training programs, which focus on hands-on surgical skills, early detection, telemedicine, and ...

Robert T. Chang, MD, from Stanford University discusses how large language models are transforming ophthalmology by enhancing ...

A group of German researchers has discovered how tiny eye movements and the density of photoreceptors assist in visual acuity ...

The investigators explained that AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions. 2 Impairment of the retinal deep capillary plexus also occurs and suggests ...

In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s ...

Observations show distinct variations between the changes in optic nerve head (ONH) and the macula.